India · Delayed Price · Currency is INR Glenmark Pharmaceuticals Statistics
Total Valuation
NSE:GLENMARK has a market cap or net worth of INR 635.09 billion. The enterprise value is 629.26 billion.
| Market Cap | 635.09B |
| Enterprise Value | 629.26B |
Important Dates
The next estimated earnings date is Friday, November 6, 2026.
| Earnings Date | Nov 6, 2026 |
| Ex-Dividend Date | Aug 31, 2026 |
Share Statistics
NSE:GLENMARK has 282.20 million shares outstanding. The number of shares has decreased by -0.00% in one year.
| Current Share Class | 282.20M |
| Shares Outstanding | 282.20M |
| Shares Change (YoY) | -0.00% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 1.24% |
| Owned by Institutions (%) | 29.40% |
| Float | 150.18M |
Valuation Ratios
The trailing PE ratio is 35.33 and the forward PE ratio is 27.00. NSE:GLENMARK's PEG ratio is 1.29.
| PE Ratio | 35.33 |
| Forward PE | 27.00 |
| PS Ratio | 3.58 |
| PB Ratio | 6.04 |
| P/TBV Ratio | 7.93 |
| P/FCF Ratio | 30.43 |
| P/OCF Ratio | 18.44 |
| PEG Ratio | 1.29 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.02, with an EV/FCF ratio of 30.15.
| EV / Earnings | 35.00 |
| EV / Sales | 3.55 |
| EV / EBITDA | 13.02 |
| EV / EBIT | 15.05 |
| EV / FCF | 30.15 |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.06 |
| Debt / EBITDA | 0.12 |
| Debt / FCF | 0.28 |
| Interest Coverage | 20.44 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 29.90% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 5.81% |
| Revenue Per Employee | 10.47M |
| Profits Per Employee | 1.06M |
| Employee Count | 16,946 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NSE:GLENMARK has paid 7.35 billion in taxes.
| Income Tax | 7.35B |
| Effective Tax Rate | 29.01% |
Stock Price Statistics
The stock price has increased by +18.90% in the last 52 weeks. The beta is 0.25, so NSE:GLENMARK's price volatility has been lower than the market average.
| Beta (5Y) | 0.25 |
| 52-Week Price Change | +18.90% |
| 50-Day Moving Average | 2,363.89 |
| 200-Day Moving Average | 2,213.20 |
| Relative Strength Index (RSI) | 41.13 |
| Average Volume (20 Days) | 616,566 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:GLENMARK had revenue of INR 177.37 billion and earned 17.98 billion in profits. Earnings per share was 63.69.
| Revenue | 177.37B |
| Gross Profit | 127.59B |
| Operating Income | 41.80B |
| Pretax Income | 25.33B |
| Net Income | 17.98B |
| EBITDA | 48.32B |
| EBIT | 41.80B |
| Earnings Per Share (EPS) | 63.69 |
Balance Sheet
The company has 11.76 billion in cash and 5.94 billion in debt, with a net cash position of 5.83 billion or 20.65 per share.
| Cash & Cash Equivalents | 11.76B |
| Total Debt | 5.94B |
| Net Cash | 5.83B |
| Net Cash Per Share | 20.65 |
| Equity (Book Value) | 105.12B |
| Book Value Per Share | 372.48 |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was 34.45 billion and capital expenditures -13.58 billion, giving a free cash flow of 20.87 billion.
| Operating Cash Flow | 34.45B |
| Capital Expenditures | -13.58B |
| Depreciation & Amortization | 6.52B |
| Net Borrowing | -23.57B |
| Free Cash Flow | 20.87B |
| FCF Per Share | 73.97 |
Margins
Gross margin is 71.94%, with operating and profit margins of 23.57% and 10.14%.
| Gross Margin | 71.94% |
| Operating Margin | 23.57% |
| Pretax Margin | 14.28% |
| Profit Margin | 10.14% |
| EBITDA Margin | 27.24% |
| EBIT Margin | 23.57% |
| FCF Margin | 12.25% |
Dividends & Yields
This stock pays an annual dividend of 5.00, which amounts to a dividend yield of 0.22%.
| Dividend Per Share | 5.00 |
| Dividend Yield | 0.22% |
| Dividend Growth (YoY) | -50.00% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 3.93% |
| FCF Payout Ratio | 3.38% |
| Buyback Yield | 0.00% |
| Shareholder Yield | 0.23% |
| Earnings Yield | 2.83% |
| FCF Yield | 3.29% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for NSE:GLENMARK is 2,512.82, which is 11.66% higher than the current price. The consensus rating is "Buy".
| Price Target | 2,512.82 |
| Price Target Difference | 11.66% |
| Analyst Consensus | Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (3Y) | 7.27% |
| EPS Growth Forecast (3Y) | 1.98% |
Stock Splits
The last stock split was on September 10, 2007. It was a forward split with a ratio of 2.
| Last Split Date | Sep 10, 2007 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |